Avara offers CDMO services to pharmaceutical companies globally in oral solid dose, lozenges and liquid sterile drug products including potent compounds, and integrated packaging.
The company has built a global site footprint by acquiring facilities from leading pharmaceutical companies. In Puerto Rico, Avara acquired Merck’s facility in Arecibo in 2015 and offers manufacturing and packaging capabilities for oral solid dose drug product, including high containment, with formulation experience in immediate and controlled release.
Contact
Sabana Hoyos, Arecibo 00688, Puerto Rico
Tel: +1 (787) 623-7000
Michele Ravara brings a global perspective and deep strategic experience to his role as general manager of AbbVie Switzerland, following nearly a decade leading the Oncology Business from a global…
In 2015, Avara, a fast-growing global pharma CDMO, acquired Merck’s plant located in Arecibo, Puerto Rico. Idalia Garcia, who has been managing the site for the last six years, explains…
In cell and gene therapy, where R&D and manufacturing are inseparable, Puerto Rico’s strong biopharma base makes it an attractive option for CGT companies. The first mover in this…
Despite being a small island in the Caribbean, measuring just 100 by 35 miles, Puerto Rico has long punched above its weight as an industrial powerhouse. Already a leading producer…
Spending almost 30 years working for a single company is almost unheard of in today’s life science industry, where executives chop and change between firms with bewildering frequency. However,…
The largest pharmaceutical hub in the Americas, Puerto Rico currently exports to 120 countries, accounting for nearly USD 53 billion in weekly biopharma shipments. Remarkably, this small Caribbean island out-exports all…
Long celebrated for its world-class pharmaceutical and medical device manufacturing, Puerto Rico is now leveraging this strong foundation to nurture a new era of research and development. Rather than shifting…
Can Puerto Rico capitalise on the Trump administration’s “make in America” push? President Donald Trump wants to bring manufacturing back to America. The last 40 years of globalisation and…
With over 80,000 people directly and indirectly employed in Puerto Rico’s biosciences sector, the island relies heavily on a skilled and stable workforce to maintain its competitive edge. But it…
Across over 50 interviews with Puerto Rican government and industry stakeholders, energy supply was continuously identified as the main barrier to growth. Puerto Rico’s ageing, centralised, and fossil fuel–dependent power…
Puerto Rico’s healthcare system is a paradox of strength and fragility. With one of the highest insurance coverage rates in the US (around 94 percent) and a long tradition of…
Víctor Ramos Otero, Secretary of Health for Puerto Rico, reflects on his first 100 days in office and the key initiatives to strengthen the island’s healthcare system. He discusses efforts…
Rolando Torres, Chief Operations Officer for CooperVision, a division of global medical device company CooperCompanies, discussed the significant growth and investment CooperVision has experienced in Puerto Rico since 2019, including…
Elba Cruz, Site Director at Haleon Puerto Rico, shares how the Guayama facility has become a critical manufacturing hub for Haleon’s global operations, driven by a skilled local workforce, robust…
See our Cookie Privacy Policy Here
